Aprea announces efficacy and safety data for APR-246 in ovarian cancer
Aprea has presented clinical data from the Phase Ib part of the ongoing PiSARRO Phase Ib/II trial of APR-246.
Click on this link for more information.
top of page
bottom of page
Aprea has presented clinical data from the Phase Ib part of the ongoing PiSARRO Phase Ib/II trial of APR-246.
Click on this link for more information.
